Map2k4 (mitogen activated protein kinase kinase 4) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Map2k4 (mitogen activated protein kinase kinase 4) Rattus norvegicus
Analyze
Symbol: Map2k4
Name: mitogen activated protein kinase kinase 4
RGD ID: 1307040
Description: Enables JUN kinase kinase activity. Involved in several processes, including cell growth involved in cardiac muscle cell development; cellular response to sorbitol; and positive regulation of JNK cascade. Located in axon; dendrite cytoplasm; and perikaryon. Used to study transient cerebral ischemia. Human ortholog(s) of this gene implicated in colorectal cancer; ovarian serous carcinoma; pancreatic cancer; respiratory system cancer (multiple); and urinary bladder cancer. Orthologous to human MAP2K4 (mitogen-activated protein kinase kinase 4); PARTICIPATES IN c-Jun N-terminal kinases MAPK signaling pathway; Rho/Rac/Cdc42 mediated signaling pathway; ceramide signaling pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; acetamide.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: dual specificity mitogen-activated protein kinase kinase 4; LOC287398; MAP2K4delta; MKK4; SAPK/ERK kinase 1; Sek1
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Black Rat
Alliance Orthologs
More Info more info ...
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81050,842,348 - 50,947,063 (-)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1050,844,034 - 50,947,185 (-)EnsemblGRCr8
mRatBN7.21050,343,227 - 50,447,956 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1050,344,915 - 50,447,993 (-)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1055,014,269 - 55,116,147 (-)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01054,504,259 - 54,606,140 (-)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01050,012,148 - 50,114,010 (-)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01052,196,121 - 52,301,887 (-)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1052,196,124 - 52,290,657 (-)Ensemblrn6Rnor6.0
Rnor_5.01051,951,707 - 52,054,098 (-)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41052,009,149 - 52,041,599 (-)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1049,553,065 - 49,624,419 (-)NCBICelera
RGSC_v3.11052,020,408 - 52,055,249 (-)NCBI
Cytogenetic Map10q24NCBI
JBrowse:




Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
1,2-dimethylhydrazine  (ISO)
17beta-estradiol  (ISO)
17beta-hydroxy-5alpha-androstan-3-one  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4,6-tribromophenol  (ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxyphenyl retinamide  (ISO)
6-propyl-2-thiouracil  (EXP)
acetamide  (EXP)
Aciculatin  (ISO)
acrylamide  (ISO)
actinomycin D  (ISO)
afimoxifene  (ISO)
aflatoxin B1  (ISO)
alpha-mangostin  (ISO)
alvocidib  (ISO)
andrographolide  (ISO)
Antimony trioxide  (ISO)
antimycin A  (ISO)
antirheumatic drug  (ISO)
aristolochic acid A  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
auramine O  (ISO)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bisphenol A  (EXP,ISO)
bortezomib  (ISO)
butylated hydroxyanisole  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (ISO)
celecoxib  (ISO)
chlorogenic acid  (ISO)
chromium(6+)  (ISO)
cisplatin  (ISO)
cobalt dichloride  (ISO)
cocaine  (ISO)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
crocidolite asbestos  (ISO)
curcumin  (ISO)
cyclosporin A  (ISO)
cypermethrin  (ISO)
decabromodiphenyl ether  (ISO)
deoxynivalenol  (ISO)
diallyl trisulfide  (ISO)
diarsenic trioxide  (ISO)
dicrotophos  (ISO)
disodium selenite  (ISO)
doxorubicin  (ISO)
endosulfan  (ISO)
ethanol  (ISO)
folic acid  (ISO)
fulvestrant  (ISO)
gallic acid  (ISO)
gingerol  (ISO)
glyphosate  (ISO)
hydrogen cyanide  (ISO)
hydrogen peroxide  (ISO)
indometacin  (ISO)
isoprenaline  (EXP)
ivermectin  (ISO)
Licochalcone A  (ISO)
lipopolysaccharide  (ISO)
lycopene  (ISO)
maneb  (ISO)
manganese atom  (ISO)
manganese(0)  (ISO)
manganese(II) chloride  (EXP)
methidathion  (ISO)
methotrexate  (ISO)
mevinphos  (EXP)
mono(2-ethylhexyl) phthalate  (ISO)
monosodium L-glutamate  (EXP)
N-acetyl-L-cysteine  (EXP,ISO)
N-nitrosodiethylamine  (ISO)
N-nitrosodimethylamine  (EXP)
nickel dichloride  (ISO)
okadaic acid  (ISO)
p-menthan-3-ol  (ISO)
paclitaxel  (ISO)
paracetamol  (EXP,ISO)
paraquat  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
phenylarsine oxide  (ISO)
phorbol 13-acetate 12-myristate  (ISO)
picoxystrobin  (ISO)
pyrrolidine dithiocarbamate  (EXP)
quercetin  (EXP,ISO)
reactive oxygen species  (ISO)
scutellarin  (ISO)
sodium arsenite  (ISO)
sorafenib  (ISO)
streptozocin  (ISO)
sulforaphane  (ISO)
sulindac sulfone  (ISO)
tamoxifen  (ISO)
tebufenpyrad  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (ISO)
thapsigargin  (ISO)
thiram  (ISO)
topotecan  (EXP)
triphenyl phosphate  (ISO)
valproic acid  (ISO)
vinclozolin  (EXP)
zearalenone  (ISO)
zinc dichloride  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component
axon  (IDA)
cytosol  (IEA)
dendrite cytoplasm  (IDA)
perikaryon  (IDA)

References

References - curated
# Reference Title Reference Citation
1. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression. Ahn YH, etal., Mol Cell Biol. 2011 Nov;31(21):4270-85. doi: 10.1128/MCB.05562-11. Epub 2011 Sep 6.
2. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Auer KL, etal., Mol Biol Cell. 1998 Mar;9(3):561-73.
3. Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms. Butterfield L, etal., Biochem J. 1999 Mar 15;338 ( Pt 3):681-6.
4. Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death. Chang AY J Biomed Sci. 2012 Nov 17;19:96. doi: 10.1186/1423-0127-19-96.
5. Influence of sleep deprivation on expression of MKK4 and c-fos in the mandibular condylar cartilage of rats. Chen J, etal., Br J Oral Maxillofac Surg. 2013 Dec;51(8):e250-5. doi: 10.1016/j.bjoms.2013.06.010. Epub 2013 Jul 13.
6. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. Choukroun G, etal., J Clin Invest. 1998 Oct 1;102(7):1311-20.
7. Toll-like receptor 2-mediated sequential activation of MyD88 and MAPKs contributes to lipopolysaccharide-induced sp-a gene expression in human alveolar epithelial cells. Chuang CY, etal., Immunobiology. 2011 Jun;216(6):707-14. doi: 10.1016/j.imbio.2010.10.009. Epub 2010 Nov 4.
8. The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer. Finegan KG and Tournier C, Cancer Res. 2010 Jul 15;70(14):5797-806. doi: 10.1158/0008-5472.CAN-09-3669. Epub 2010 Jul 7.
9. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. Flood DG, etal., J Comp Neurol. 1998 Aug 31;398(3):373-92.
10. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
11. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
12. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells. Guan Z, etal., J Biol Chem. 1999 Dec 17;274(51):36200-6.
13. Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia. Harding SJ, etal., Biochim Biophys Acta. 2010 Sep;1802(9):733-40. doi: 10.1016/j.bbadis.2010.06.005. Epub 2010 Jun 13.
14. Increased expression of IRE1alpha and stress-related signal transduction proteins in ischemia-reperfusion injured retina. Hata N, etal., Clin Ophthalmol. 2008 Dec;2(4):743-52.
15. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Hickson JA, etal., Cancer Res. 2006 Feb 15;66(4):2264-70.
16. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Hildebrandt MA, etal., Sci Rep. 2015 Jul 13;5:12068. doi: 10.1038/srep12068.
17. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Huang C, etal., Oncol Rep. 2009 Jul;22(1):89-95.
18. [The relationship between expression of mitogen-activated protein kinase kinase 4 and metastasis in oral squamous cell carcinoma]. Jiang N, etal., Hua Xi Kou Qiang Yi Xue Za Zhi. 2011 Oct;29(5):555-8.
19. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Johnson GL and Nakamura K, Biochim Biophys Acta. 2007 Aug;1773(8):1341-8. Epub 2007 Jan 4.
20. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Jones S, etal., Science. 2008 Sep 26;321(5897):1801-6. Epub 2008 Sep 4.
21. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Kim HL, etal., Cancer Res. 2001 Apr 1;61(7):2833-7.
22. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Koed K, etal., Cancer Res. 2005 Jan 1;65(1):34-45.
23. 7,3',4'-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4. Lee DE, etal., J Biol Chem. 2011 Apr 22;286(16):14246-56. doi: 10.1074/jbc.M110.147348. Epub 2011 Mar 4.
24. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Lee HY, etal., Clin Cancer Res. 2002 Sep;8(9):2970-5.
25. Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway. Liang T, etal., Int J Mol Sci. 2014 Sep 5;15(9):15754-65. doi: 10.3390/ijms150915754.
26. A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity. Liu B, etal., Carcinogenesis. 2010 Aug;31(8):1405-11. doi: 10.1093/carcin/bgq126. Epub 2010 Jun 16.
27. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. Lotan TL, etal., J Pathol. 2007 Aug;212(4):386-94.
28. [Association between MKK4 promoter-1304T/G polymorphism and genetic susceptibility in sporadic nasopharyngeal carcinoma]. Lu M, etal., Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Feb;30(4):287-90.
29. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
30. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. Mizukami Y, etal., J Biol Chem. 1997 Jun 27;272(26):16657-62.
31. Evidence for multiple activators for stress-activated protein kinase/c-Jun amino-terminal kinases. Existence of novel activators. Moriguchi T, etal., J Biol Chem. 1995 Jun 2;270(22):12969-72.
32. Homozygous deletion of MKK4 in ovarian serous carcinoma. Nakayama K, etal., Cancer Biol Ther. 2006 Jun;5(6):630-4. Epub 2006 Jun 9.
33. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Park HJ, etal., Hepatology. 2002 Jun;35(6):1360-71.
34. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
35. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
36. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
37. GOA pipeline RGD automated data pipeline
38. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
39. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
40. The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill. Rui T, etal., Front Oncol. 2020 Aug 7;10:1244. doi: 10.3389/fonc.2020.01244. eCollection 2020.
41. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. Stark AM, etal., J Cancer Res Clin Oncol. 2005 Mar;131(3):191-8. Epub 2004 Dec 8.
42. Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Tkacova R, etal., Respiration. 2011;81(5):386-93. Epub 2010 Aug 12.
43. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Vander Griend DJ, etal., Cancer Res. 2005 Dec 1;65(23):10984-91.
44. Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats. Wang R, etal., J Neurochem. 2006 Dec;99(6):1543-54. Epub 2006 Oct 25.
45. Association of genetic variation in mitotic kinases with breast cancer risk. Wang X, etal., Breast Cancer Res Treat. 2010 Jan;119(2):453-62. doi: 10.1007/s10549-009-0404-3. Epub 2009 Apr 30.
46. The association between -1304T>G polymorphism in the promoter of MKK4 gene and the risk of sporadic colorectal cancer in southern Chinese population. Wei Y, etal., Int J Cancer. 2009 Oct 15;125(8):1876-83. doi: 10.1002/ijc.24575.
47. Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Wu CW, etal., Am J Pathol. 2000 Jun;156(6):2007-15. doi: 10.1016/s0002-9440(10)65073-0.
48. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4. Wu X, etal., Cell Prolif. 2017 Jun;50(3). doi: 10.1111/cpr.12336. Epub 2017 Mar 20.
49. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. Xu Z, etal., EMBO J. 2003 Jan 15;22(2):252-61.
50. Biphasic activation of apoptosis signal-regulating kinase 1-stress-activated protein kinase 1-c-Jun N-terminal protein kinase pathway is selectively mediated by Ca2+-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors involving oxidative stress following brain ischemia in rat hippocampus. Zhang Q, etal., Neurosci Lett. 2003 Jan 30;337(1):51-5.
51. Blockade of the translocation and activation of mitogen-activated protein kinase kinase 4 (MKK4) signaling attenuates neuronal damage during later ischemia-reperfusion. Zhang QX, etal., J Neurochem. 2006 Jul;98(1):170-9.
52. The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status. Zheng J, etal., Int J Cancer. 2012 May 1;130(9):1981-90. doi: 10.1002/ijc.26253. Epub 2011 Aug 25.
53. Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesis. Zi M, etal., J Biol Chem. 2011 May 20;286(20):17821-30. doi: 10.1074/jbc.M111.228791. Epub 2011 Mar 28.
Additional References at PubMed
PMID:12556533   PMID:17559804   PMID:17568772   PMID:19248828   PMID:19593445   PMID:21351092   PMID:24487067   PMID:24705900   PMID:24721794   PMID:25100604   PMID:29072705   PMID:31710596  
PMID:36164393  


Genomics

Comparative Map Data
Map2k4
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81050,842,348 - 50,947,063 (-)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1050,844,034 - 50,947,185 (-)EnsemblGRCr8
mRatBN7.21050,343,227 - 50,447,956 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1050,344,915 - 50,447,993 (-)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1055,014,269 - 55,116,147 (-)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01054,504,259 - 54,606,140 (-)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01050,012,148 - 50,114,010 (-)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01052,196,121 - 52,301,887 (-)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1052,196,124 - 52,290,657 (-)Ensemblrn6Rnor6.0
Rnor_5.01051,951,707 - 52,054,098 (-)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41052,009,149 - 52,041,599 (-)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1049,553,065 - 49,624,419 (-)NCBICelera
RGSC_v3.11052,020,408 - 52,055,249 (-)NCBI
Cytogenetic Map10q24NCBI
MAP2K4
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381712,020,877 - 12,143,828 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1712,020,828 - 12,143,830 (+)Ensemblhg38GRCh38
GRCh371711,924,194 - 12,047,145 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361711,864,860 - 11,987,776 (+)NCBIBuild 36Build 36hg18NCBI36
Build 341711,864,859 - 11,987,775NCBI
Celera1711,954,698 - 12,077,624 (+)NCBICelera
Cytogenetic Map17p12ENTREZGENE
HuRef1711,825,033 - 11,947,931 (+)NCBIHuRef
CHM1_11711,933,251 - 12,056,267 (+)NCBICHM1_1
T2T-CHM13v2.01711,928,859 - 12,051,837 (+)NCBIT2T-CHM13v2.0
Map2k4
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391165,579,070 - 65,679,185 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1165,579,069 - 65,679,123 (-)EnsemblGRCm39 EnsemblGRCm39
GRCm381165,688,244 - 65,788,359 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1165,688,243 - 65,788,297 (-)Ensemblmm10GRCm38
MGSCv371165,501,746 - 65,601,799 (-)NCBIMGSCv37MGSCv37mm9NCBIm37
MGSCv361165,504,439 - 65,604,492 (-)NCBIMGSCv36mm8
Celera1172,623,125 - 72,726,188 (-)NCBICelera
Cytogenetic Map11B3NCBI
cM Map1140.53NCBI
Map2k4
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554675,187,356 - 5,307,692 (-)Ensembl
ChiLan1.0NW_0049554675,188,036 - 5,295,570 (-)NCBIChiLan1.0ChiLan1.0
MAP2K4
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21961,596,659 - 61,721,974 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11766,403,318 - 66,528,369 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01739,497,105 - 39,622,331 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11744,246,301 - 44,359,906 (-)NCBIPanPan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1744,248,857 - 44,359,909 (-)EnsemblpanPan2panpan1.1
MAP2K4
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1536,142,610 - 36,243,673 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl536,118,388 - 36,241,296 (+)EnsemblcanFam3CanFam3.1
Dog10K_Boxer_Tasha536,246,628 - 36,382,182 (+)NCBIDog10K_Boxer_TashaDog10K_Boxer_Tasha
ROS_Cfam_1.0536,216,260 - 36,351,866 (+)NCBIROS_Cfam_1.0ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl536,216,250 - 36,351,818 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1536,183,407 - 36,318,935 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0536,137,113 - 36,272,679 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0536,321,228 - 36,456,796 (+)NCBIUU_Cfam_GSD_1.0UU_Cfam_GSD_1.0
Map2k4
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440560251,288,135 - 51,356,168 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365954,727,108 - 4,830,662 (+)EnsemblSpeTri2.0 Ensembl
SpeTri2.0NW_0049365954,762,327 - 4,828,433 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
MAP2K4
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1256,402,075 - 56,516,238 (+)EnsemblsusScr11Sscrofa11.1
Sscrofa11.11256,402,029 - 56,516,217 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21259,330,511 - 59,409,571 (+)NCBISscrofa10.2Sscrofa10.2susScr3
MAP2K4
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.11611,366,610 - 11,485,411 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl1611,366,751 - 11,486,125 (+)EnsemblChlSab1.1 EnsemblchlSab2Vervet-AGM
Vero_WHO_p1.0NW_0236660599,768,762 - 9,889,281 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Map2k4
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462478614,457,452 - 14,597,027 (+)EnsemblHetGla_female_1.0 EnsemblhetGla2HetGla_female_1.0 Ensembl
HetGla 1.0NW_00462478614,457,382 - 14,597,027 (+)NCBIHetGla 1.0HetGla 1.0hetGla2
Map2k4
(Rattus rattus - black rat)
Black Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rrattus_CSIRO_v1945,295,943 - 45,392,383 (-)NCBIRrattus_CSIRO_v1

Variants

.
Variants in Map2k4
588 total Variants
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:37
Count of miRNA genes:34
Interacting mature miRNAs:37
Transcripts:ENSRNOT00000005293
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
61441Btemp1Thermal response to stress QTL 14body temperature trait (VT:0005535)core body temperature (CMO:0001036)103589345164140567Rat
152025229Scl83Serum cholesterol level QTL 834.33blood cholesterol amount (VT:0000180)103621155669161158Rat
1578779Tcas10Tongue tumor susceptibility QTL 103.12tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950)103179628176796281Rat
152025227Bw195Body weight QTL 1955.73body mass (VT:0001259)104748901769161158Rat
631564Apr3Acute phase response QTL 33.9blood interleukin-6 amount (VT:0008595)plasma interleukin-6 level (CMO:0001927)101577675460776754Rat
1298069Bp168Blood pressure QTL 1685.5blood pressure trait (VT:0000183)systolic blood pressure (CMO:0000004)102702353598502431Rat
2293669Bmd33Bone mineral density QTL 334.50.0001femur strength trait (VT:0010010)femoral neck polar moment of inertia (CMO:0001670)102744378772443787Rat
631552Vetf2Vascular elastic tissue fragility QTL 24.50.0002aorta elastic tissue integrity trait (VT:0010556)artery internal elastic lamina non-tumorous lesion count (CMO:0001913)103550938391417879Rat
631554Bp133Blood pressure QTL 1330.005arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)10125055464349221Rat
61325Aia5Adjuvant induced arthritis QTL 50.01joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023948641107713808Rat
2293679Bmd30Bone mineral density QTL 303.50.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)102744378772443787Rat
1298078Stresp5Stress response QTL 52.990.00025blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)1042546145107713808Rat
1578761Stresp21Stress response QTL 213.3thymus mass (VT:0004954)thymus wet weight (CMO:0000855)10687714251877142Rat
2298544Neuinf9Neuroinflammation QTL 94.6nervous system integrity trait (VT:0010566)spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)101993920764939207Rat
61332Eau3Experimental allergic uveoretinitis QTL 30.004uvea integrity trait (VT:0010551)experimental autoimmune uveitis score (CMO:0001504)101803578263035782Rat
61463Bp12Blood pressure QTL 126.30.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)104183127886831278Rat
1579919Bp281Blood pressure QTL 2810.01arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)105046480295464802Rat
8694173Bw149Body weight QTL 1494.380.001body mass (VT:0001259)body weight gain (CMO:0000420)104493935989939359Rat
2300218Hpcl2Hepatic cholesterol level QTL 2liver cholesterol amount (VT:0010498)liver cholesterol level (CMO:0001597)104552916496099749Rat
1598852Anxrr19Anxiety related response QTL 195.07body movement coordination trait (VT:0005424)number of rearing movements in an experimental apparatus (CMO:0001752)101866841963668419Rat
1581497Esta1Estrogen-induced thymic atrophy QTL 1thymus mass (VT:0004954)thymus wet weight (CMO:0000855)102183375861843633Rat
10450493Bp382Blood pressure QTL 3820.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)105086028895860288Rat
2313095Bss62Bone structure and strength QTL 621.50.0001tibia size trait (VT:0100001)tibia midshaft cross-sectional area (CMO:0001717)10589381150893811Rat
724527Bp148Blood pressure QTL 1480.0001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)102895035373950353Rat
1358897Stresp6Stress response QTL 64.170.022blood norepinephrine amount (VT:0005663)plasma norepinephrine level (CMO:0001010)103589326364653589Rat
1331762Rf40Renal function QTL 403.873kidney blood vessel physiology trait (VT:0100012)absolute change in renal vascular resistance (CMO:0001900)102980091064653589Rat
2300171Bmd58Bone mineral density QTL 584.90.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)102744378772443787Rat
61354Pia10Pristane induced arthritis QTL 100.01joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023948641107713808Rat
2301967Cm73Cardiac mass QTL 734.55heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)101499153586964295Rat
70188BpQTLcluster1Blood pressure QTL cluster 14.864arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)14282327487823274Rat
2313104Bss61Bone structure and strength QTL 610.90.0001tibia area (VT:1000281)tibia midshaft cross-sectional area (CMO:0001717)10589381150893811Rat
9589030Epfw9Epididymal fat weight QTL 919.240.001epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)104493935989939359Rat
2316949Gluco60Glucose level QTL 603.7blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1014991535107556066Rat
2293652Bmd22Bone mineral density QTL 224.90.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)102744378772443787Rat
70198BpQTLcluster9Blood pressure QTL cluster 92.94arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)104282327487823274Rat
724556Pur2Proteinuria QTL 25.5urine protein amount (VT:0005160)urine protein level (CMO:0000591)102293137391127454Rat
8662860Vetf10Vascular elastic tissue fragility QTL 10artery integrity trait (VT:0010639)number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562)10666092373950353Rat
2313066Bss63Bone structure and strength QTL 631.40.0001tibia strength trait (VT:1000284)bone polar moment of inertia (CMO:0001558)10589381150893811Rat
2313064Bmd71Bone mineral density QTL 710.90.0001tibia mineral mass (VT:1000283)compact volumetric bone mineral density (CMO:0001730)10589381150893811Rat
2306792Ean4Experimental allergic neuritis QTL 44nervous system integrity trait (VT:0010566)IFNG-secreting splenocyte count (CMO:0002122)104949549294495492Rat
70223Bp57Blood pressure QTL 575arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)101465354159653541Rat
1354587Kidm21Kidney mass QTL 213.3kidney mass (VT:0002707)right kidney wet weight (CMO:0000082)101553301273695498Rat
634329Pia15Pristane induced arthritis QTL 153.1joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)102466212373695339Rat
70224Eae3Experimental allergic encephalomyelitis QTL 34.1nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046)102702353561843633Rat
2298480Eau7Experimental allergic uveoretinitis QTL 70.0049uvea integrity trait (VT:0010551)experimental autoimmune uveitis score (CMO:0001504)103550938380509383Rat
2313081Bss64Bone structure and strength QTL 641.30.0001tibia strength trait (VT:1000284)tibia total energy absorbed before break (CMO:0001736)10589381150893811Rat
1331791Cm31Cardiac mass QTL 313.84606heart mass (VT:0007028)heart wet weight (CMO:0000069)102980091091417879Rat
2298495Eae23Experimental allergic encephalomyelitis QTL 2316.93nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis duration (CMO:0001424)101617552561175525Rat
2313087Bmd80Bone mineral density QTL 803.20.0001tibia mineral mass (VT:1000283)total volumetric bone mineral density (CMO:0001728)102011061465110614Rat
1354614Hpcl1Hepatic cholesterol level QTL 13.3liver cholesterol amount (VT:0010498)liver cholesterol level (CMO:0001597)103589326352293000Rat
631530Tls3T-lymphoma susceptibility QTL 300.0001thymus integrity trait (VT:0010555)percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911)102758722696099902Rat
2289985Bp305Blood pressure QTL 305arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)102907697874076978Rat
631532Cm50Cardiac mass QTL 506.6heart mass (VT:0007028)calculated heart weight (CMO:0000073)101803578263035782Rat
8552805Bw145Body weight QTL 1452.2body mass (VT:0001259)change in body weight to body weight ratio (CMO:0002216)104360879388608793Rat
631267Cia20Collagen induced arthritis QTL 203.2joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023948641107713808Rat
2293705Bmd25Bone mineral density QTL 257.10.0001femur mineral mass (VT:0010011)compact volumetric bone mineral density (CMO:0001730)102744378772443787Rat
1600371Mcs21Mammary carcinoma susceptibility QTL 213mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)102937704652699134Rat
631269Cia22Collagen induced arthritis QTL 228.9joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1040535708107713808Rat
1576308Schws1Schwannoma susceptibility QTL 10.0041nervous system integrity trait (VT:0010566)percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017)1040535708107713808Rat
631268Cia21Collagen induced arthritis QTL 213.1joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1014991535107713808Rat
7207811Bmd90Bone mineral density QTL 905.2femur size trait (VT:1000369)femoral neck cross-sectional area (CMO:0001697)104994371094943710Rat
1576311Pia26Pristane induced arthritis QTL 26joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)103112911376129113Rat
631270Cia23Collagen induced arthritis QTL 233.9joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1040535708107713808Rat
7411614Foco18Food consumption QTL 180.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)104493935989939359Rat
631547Bp87Blood pressure QTL 874.5arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)104786912992869129Rat
61427Cia16Collagen induced arthritis QTL 163.2joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)10686461896620484Rat
12880050Am10Aortic mass QTL 100.016aorta mass (VT:0002845)aorta weight to aorta length to body weight ratio (CMO:0002722)103950348784503487Rat
2292436Bp310Blood pressure QTL 310arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)105060467795604677Rat
6893342Cm78Cardiac mass QTL 780.10.88heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)103550938388177745Rat
2313055Bw96Body weight QTL 963.60.0001body mass (VT:0001259)body weight (CMO:0000012)102011061465110614Rat
631542Bp82Blood pressure QTL 826.8arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)102702353599451848Rat

Markers in Region
U18310  
Rat AssemblyChrPosition (strand)SourceJBrowse
GRCr81050,844,455 - 50,844,632 (+)Marker Load Pipeline
mRatBN7.21050,345,335 - 50,345,513 (+)MAPPERmRatBN7.2
Rnor_6.01052,195,865 - 52,196,042NCBIRnor6.0
Rnor_5.01051,951,451 - 51,951,628UniSTSRnor5.0
RGSC_v3.41052,008,893 - 52,009,070UniSTSRGSC3.4
Celera1049,552,809 - 49,552,986UniSTS
Cytogenetic Map10q24UniSTS


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
visual system
16 12 67 165 91 90 59 92 59 6 356 192 11 144 81 92 31 17 17

Sequence


Ensembl Acc Id: ENSRNOT00000005293   ⟹   ENSRNOP00000005293
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1050,844,034 - 50,916,403 (-)Ensembl
mRatBN7.2 Ensembl1050,344,915 - 50,417,289 (-)Ensembl
Rnor_6.0 Ensembl1052,196,124 - 52,290,657 (-)Ensembl
Ensembl Acc Id: ENSRNOT00000109134   ⟹   ENSRNOP00000081371
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1050,844,034 - 50,947,039 (-)Ensembl
mRatBN7.2 Ensembl1050,344,915 - 50,447,932 (-)Ensembl
Ensembl Acc Id: ENSRNOT00000112493   ⟹   ENSRNOP00000095727
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1050,844,034 - 50,947,185 (-)Ensembl
mRatBN7.2 Ensembl1050,344,915 - 50,447,993 (-)Ensembl
Ensembl Acc Id: ENSRNOT00000141706   ⟹   ENSRNOP00000102620
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1050,844,034 - 50,947,039 (-)Ensembl
RefSeq Acc Id: NM_001030023   ⟹   NP_001025194
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81050,844,034 - 50,947,039 (-)NCBI
mRatBN7.21050,344,915 - 50,447,932 (-)NCBI
Rnor_6.01052,196,121 - 52,301,887 (-)NCBI
Rnor_5.01051,951,707 - 52,054,098 (-)NCBI
RGSC_v3.41052,009,149 - 52,041,599 (-)RGD
Celera1049,553,065 - 49,624,419 (-)RGD
Sequence:
RefSeq Acc Id: XM_039085426   ⟹   XP_038941354
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81050,842,348 - 50,947,063 (-)NCBI
mRatBN7.21050,343,227 - 50,447,956 (-)NCBI
RefSeq Acc Id: XM_063268626   ⟹   XP_063124696
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81050,842,348 - 50,947,061 (-)NCBI
RefSeq Acc Id: XM_063268627   ⟹   XP_063124697
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81050,842,348 - 50,947,060 (-)NCBI
RefSeq Acc Id: XM_063268628   ⟹   XP_063124698
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81050,842,348 - 50,916,010 (-)NCBI
RefSeq Acc Id: XM_063268629   ⟹   XP_063124699
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81050,842,348 - 50,916,174 (-)NCBI
RefSeq Acc Id: NP_001025194   ⟸   NM_001030023
- UniProtKB: Q4KSH6 (UniProtKB/TrEMBL),   F1LP57 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSRNOP00000005293   ⟸   ENSRNOT00000005293
RefSeq Acc Id: XP_038941354   ⟸   XM_039085426
- Peptide Label: isoform X3
- UniProtKB: S4VP54 (UniProtKB/TrEMBL),   F1LP57 (UniProtKB/TrEMBL)
Ensembl Acc Id: ENSRNOP00000081371   ⟸   ENSRNOT00000109134
Ensembl Acc Id: ENSRNOP00000095727   ⟸   ENSRNOT00000112493
RefSeq Acc Id: XP_063124696   ⟸   XM_063268626
- Peptide Label: isoform X1
- UniProtKB: F1LP57 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_063124697   ⟸   XM_063268627
- Peptide Label: isoform X2
- UniProtKB: F1LP57 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_063124699   ⟸   XM_063268629
- Peptide Label: isoform X5
RefSeq Acc Id: XP_063124698   ⟸   XM_063268628
- Peptide Label: isoform X4
- UniProtKB: F1LP57 (UniProtKB/TrEMBL)
Ensembl Acc Id: ENSRNOP00000102620   ⟸   ENSRNOT00000141706
Protein Domains
Protein kinase

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-F1LP57-F1-model_v2 AlphaFold F1LP57 1-372 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen


Additional Information

Database Acc Id Source(s)
AGR Gene RGD:1307040 AgrOrtholog
BioCyc Gene G2FUF-24703 BioCyc
Ensembl Genes ENSRNOG00000003834 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000005293.9 UniProtKB/TrEMBL
  ENSRNOT00000109134 ENTREZGENE
  ENSRNOT00000109134.2 UniProtKB/TrEMBL
  ENSRNOT00000112493 ENTREZGENE
  ENSRNOT00000112493.2 UniProtKB/TrEMBL
  ENSRNOT00000141706 ENTREZGENE
  ENSRNOT00000141706.1 UniProtKB/TrEMBL
Gene3D-CATH Phosphorylase Kinase, domain 1 UniProtKB/TrEMBL
  Transferase(Phosphotransferase) domain 1 UniProtKB/TrEMBL
InterPro Kinase-like_dom UniProtKB/TrEMBL
  Prot_kinase_cat_dom UniProtKB/TrEMBL
  Protein_kinase_ATP_BS UniProtKB/TrEMBL
  Ser/Thr_prot_kinase_AS UniProtKB/TrEMBL
KEGG Report rno:287398 UniProtKB/TrEMBL
NCBI Gene 287398 ENTREZGENE
PANTHER DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 UniProtKB/TrEMBL
  DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5-RELATED UniProtKB/TrEMBL
Pfam Pkinase UniProtKB/TrEMBL
PhenoGen Map2k4 PhenoGen
PIRSF Integrin-linked_kinase UniProtKB/TrEMBL
PROSITE PROTEIN_KINASE_ATP UniProtKB/TrEMBL
  PROTEIN_KINASE_DOM UniProtKB/TrEMBL
  PROTEIN_KINASE_ST UniProtKB/TrEMBL
RatGTEx ENSRNOG00000003834 RatGTEx
SMART S_TKc UniProtKB/TrEMBL
Superfamily-SCOP Kinase_like UniProtKB/TrEMBL
UniProt A0A8I5ZS39_RAT UniProtKB/TrEMBL
  A0ABK0L269_RAT UniProtKB/TrEMBL
  A6HFF9_RAT UniProtKB/TrEMBL
  F1LP57 ENTREZGENE, UniProtKB/TrEMBL
  Q4KSH6 ENTREZGENE, UniProtKB/TrEMBL
  S4VP54 ENTREZGENE, UniProtKB/TrEMBL


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2005-12-06 Map2k4  mitogen activated protein kinase kinase 4  Map2k4_predicted  mitogen activated protein kinase kinase 4 (predicted)  Symbol and Name updated 1559027 APPROVED
2005-01-12 Map2k4_predicted  mitogen activated protein kinase kinase 4 (predicted)      Symbol and Name status set to approved 70820 APPROVED